Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (DE:CVS)
XETRA:CVS
CVS Stock Chart & Stats
€66.27
€0.44(0.98%)
At close: 4:00 PM EST
€66.27
€0.44(0.98%)
Day’s Range― - ―
52-Week Range€50.05 - €73.65
Previous CloseN/A
Volume168.00
Average Volume (3M)649.00
Market Cap
€84.30B
Enterprise Value€170.98B
Total Cash (Recent Filing)€10.66B
Total Debt (Recent Filing)€93.59B
Price to Earnings (P/E)53.8
Beta0.47
Next Earnings
May 06, 2026EPS Estimate
1.88Next Dividend Ex-DateN/A
Dividend Yield3.51%
Share Statistics
EPS (TTM)0.92
Shares Outstanding1,272,211,000
10 Day Avg. Volume1,051
30 Day Avg. Volume649
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€81.26Price Target Upside22.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings And GuidanceStrong operating results and segment earnings that exceeded analyst expectations, together with reaffirmed revenue and operating income guidance, support confidence in the company's earnings trajectory.
Retail Market Share And Store FootprintMarket share gains in the retail segment and increased focus on improving the in-store experience are driving operating income growth and could be a durable bright spot for the business.
Technology Platform And Long-term GrowthIntroduction of an Open Engagement Platform as part of a sizable technology investment positions the company to expand partner relationships and capture future earnings upside through better care coordination.
Bears Say
Cash Flow And Medical Cost PressuresLowered cash flow expectations tied to payment timing and working-capital shifts, combined with persistently elevated medical costs across product lines, reduce near-term liquidity and pressure profitability.
Medicare Advantage Payment RiskProposed Medicare Advantage payment changes and a revised risk-adjustment approach that excludes certain chart reviews would reduce reimbursements and place material pressure on Medicare Advantage margins and care-delivery revenue.
PBM Margin PressureA market shift toward fee-based PBM compensation and an increasingly complex PBM environment pose headwinds to future PBM margins and could weigh on near-term earnings growth.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €50.05 and its highest was €73.65 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is €84.30B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is May 06, 2026 which is in 77 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Feb 10, 2026. The company reported €0.918 earnings per share for the quarter, beating the consensus estimate of €0.845 by €0.073.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of €0.572 which represents an annual dividend yield of 3.51%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.88.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,272,211,000 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €0.918 in its last earnings report, beating expectations of €0.845. Following the earnings report the stock price went down -0.883%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in DE:CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€81.26 (22.62% Upside)
€81.26 (22.62% Upside)
Blogger Sentiment
Bullish
DE:CVS Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $1.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.75%
12-Months-Change
Fundamentals
Return on Equity
2.35%
Trailing 12-Months
Asset Growth
0.09%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Company Deck
CVS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted multiple clear operational and financial improvements across the enterprise — strong revenue growth, meaningful EPS and cash‑flow outperformance for 2025, substantial YoY profit recovery at Aetna, robust pharmacy momentum (same‑store and script gains), sizable client savings and strategic wins (cost‑based reimbursement, TrueCost, HUMIRA biosimilar adoption). Key challenges include an unfavorable preliminary 2027 Medicare Advantage rate notice, a Q4 adjusted operating loss in Health Care Benefits driven by Part D seasonality, membership declines in certain blocks, regulatory uncertainty for PBM dynamics and persistent elevated medical cost trends. Overall, the positive operational momentum, reaffirmed 2026 guidance, and improved cash and leverage profile outweigh the headwinds, though management noted material risks they are actively addressing.View all DE:CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
€81.26
▲(22.62% Upside)
Technical Analysis
Options Prices
Currently, No data available
---